Skip to main content

Table 3 Correlation between miRNA levels and surface markers

From: MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

  miR-96 (per million) miR-182 (per million) miR-183 (per million)
ER− (n = 185) 46.9 ± 37.1 42764.4 ± 29615.6 23463.0 ± 18606.7
ER + (n = 643) 40.5 ± 32.2* 49378.5 ± 32671.3* 17756.8 ± 12451.0***
PR+ (n = 265) 45.6 ± 34.7 45513.2 ± 32873.7 22037.2 ± 16212.9
PR + (n = 561) 40.2 ± 32.8* 49013.4 ± 31716.4 17628.8 ± 12993.5***
HER2− (n = 512) 40.7 ± 34.5 47943.7 ± 32825.1 18532.7 ± 14331.1
HER2+ (n = 144) 41.8 ± 32.5 44664.8 ± 28806.9 19404.0 ± 14591.3
  1. The expression of each miRNA in the miR-183/-96/182 cluster in different breast cancer subtypes based on their surface markers: Patient number is indicated in the first column. Data are presented as mean ± SD. Statistical probability (P) was expressed as *P<0.05, ***P<0.001. ER, estrogen receptor; PR, progesterone receptor; HER, human epidermal growth factor receptor.